98 related articles for article (PubMed ID: 22235309)
1. The CEACAM1 N-terminal Ig domain mediates cis- and trans-binding and is essential for allosteric rearrangements of CEACAM1 microclusters.
Klaile E; Vorontsova O; Sigmundsson K; Müller MM; Singer BB; Ofverstedt LG; Svensson S; Skoglund U; Obrink B
J Cell Biol; 2009 Nov; 187(4):553-67. PubMed ID: 19948502
[TBL] [Abstract][Full Text] [Related]
2. cis Interaction of the cell adhesion molecule CEACAM1 with integrin beta(3).
Brümmer J; Ebrahimnejad A; Flayeh R; Schumacher U; Löning T; Bamberger AM; Wagener C
Am J Pathol; 2001 Aug; 159(2):537-46. PubMed ID: 11485912
[TBL] [Abstract][Full Text] [Related]
3. The Moraxella adhesin UspA1 binds to its human CEACAM1 receptor by a deformable trimeric coiled-coil.
Conners R; Hill DJ; Borodina E; Agnew C; Daniell SJ; Burton NM; Sessions RB; Clarke AR; Catto LE; Lammie D; Wess T; Brady RL; Virji M
EMBO J; 2008 Jun; 27(12):1779-89. PubMed ID: 18497748
[TBL] [Abstract][Full Text] [Related]
4. CEACAM1 and the regulation of mucosal inflammation.
Nagaishi T; Chen Z; Chen L; Iijima H; Nakajima A; Blumberg RS
Mucosal Immunol; 2008 Nov; 1 Suppl 1(0 1):S39-42. PubMed ID: 19079227
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of the cytoplasmic domain of human CD99 type I.
Kim HY; Kim YM; Shin YK; Park SH; Lee W
Mol Cells; 2004 Aug; 18(1):24-9. PubMed ID: 15359120
[TBL] [Abstract][Full Text] [Related]
6. Structure of the N-terminal dimerization domain of CEACAM7.
Bonsor DA; Beckett D; Sundberg EJ
Acta Crystallogr F Struct Biol Commun; 2015 Sep; 71(Pt 9):1169-75. PubMed ID: 26323304
[TBL] [Abstract][Full Text] [Related]
7. Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions.
Birtley JR; Alomary M; Zanini E; Antony J; Maben Z; Weaver GC; Von Arx C; Mura M; Marinho AT; Lu H; Morecroft EVN; Karali E; Chayen NE; Tate EW; Jurewicz M; Stern LJ; Recchi C; Gabra H
Nat Commun; 2019 Jul; 10(1):3134. PubMed ID: 31316070
[TBL] [Abstract][Full Text] [Related]
8. CEACAM1: Shielding the liver against fibrosis.
Zhang K
Eur J Clin Invest; 2024 Feb; ():e14182. PubMed ID: 38424027
[No Abstract] [Full Text] [Related]
9. Antibodies to variable surface antigens induce antigenic variation in the intestinal parasite Giardia lamblia.
Tenaglia AH; Luján LA; Ríos DN; Molina CR; Midlej V; Iribarren PA; Berazategui MA; Torri A; Saura A; Peralta DO; Rodríguez-Walker M; Fernández EA; Petiti JP; Serradell MC; Gargantini PR; Sparwasser T; Alvarez VE; de Souza W; Luján HD
Nat Commun; 2023 May; 14(1):2537. PubMed ID: 37137944
[TBL] [Abstract][Full Text] [Related]
10. Human CEACAM1 N-domain dimerization is independent from glycan modifications.
Belcher Dufrisne M; Swope N; Kieber M; Yang JY; Han J; Li J; Moremen KW; Prestegard JH; Columbus L
Structure; 2022 May; 30(5):658-670.e5. PubMed ID: 35219398
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation Alters Dimerization Properties of a Cell-surface Signaling Protein, Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1).
Zhuo Y; Yang JY; Moremen KW; Prestegard JH
J Biol Chem; 2016 Sep; 291(38):20085-95. PubMed ID: 27471271
[TBL] [Abstract][Full Text] [Related]
12. The human antibody fragment DIATHIS1 specific for CEACAM1 enhances natural killer cell cytotoxicity against melanoma cell lines in vitro.
Dupuis ML; Fiori V; Soriani A; Ricci B; Dominici S; Moricoli D; Ascione A; Santoni A; Magnani M; Cianfriglia M
J Immunother; 2015; 38(9):357-70. PubMed ID: 26448580
[TBL] [Abstract][Full Text] [Related]
13. A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties.
Aqil M; Elseth KM; Arjunakani A; Nebres P; Amegashie CP; Thanki DH; Desai PB; Radosevich JA
Tumour Biol; 2015 Mar; 36(3):1871-9. PubMed ID: 25500969
[TBL] [Abstract][Full Text] [Related]
14. Signaling by epithelial members of the CEACAM family - mucosal docking sites for pathogenic bacteria.
Tchoupa AK; Schuhmacher T; Hauck CR
Cell Commun Signal; 2014 Apr; 12():27. PubMed ID: 24735478
[TBL] [Abstract][Full Text] [Related]
15. The transmembrane domain of CEACAM1-4S is a determinant of anchorage independent growth and tumorigenicity.
Lawson EL; Mills DR; Brilliant KE; Hixson DC
PLoS One; 2012; 7(1):e29606. PubMed ID: 22235309
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the cytoplasmic domain of CEACAM1-4L in humanized mammary glands reveals key residues involved in lumen formation: stimulation by Thr-457 and inhibition by Ser-461.
Li C; Chen CJ; Shively JE
Exp Cell Res; 2009 Apr; 315(7):1225-33. PubMed ID: 19146852
[TBL] [Abstract][Full Text] [Related]
17. Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation.
Yokoyama S; Chen CJ; Nguyen T; Shively JE
Oncogene; 2007 Dec; 26(55):7637-46. PubMed ID: 17546042
[TBL] [Abstract][Full Text] [Related]
18. Inside-out signaling promotes dynamic changes in the carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1) oligomeric state to control its cell adhesion properties.
Patel PC; Lee HS; Ming AY; Rath A; Deber CM; Yip CM; Rocheleau JV; Gray-Owen SD
J Biol Chem; 2013 Oct; 288(41):29654-69. PubMed ID: 24005674
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
